Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,108 public trials 620 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Phase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia.

NCT03672695

Conditions
Acute Myeloid Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Smilow Cancer Hospital at Yale New Haven, Connecticut, United States
  • The University of Texas MD Anderson Cancer Center, Houston, TX Houston, Texas, United States
  • Peter MacCallum cancer centrer Melbourne, Australia
  • The Alfred Hospital Department of Haematology Victoria Park, Australia
View Trial Details
Completed

Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.

NCT01041508

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +17 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Nationwide Childrens Hospital Columbus, Ohio, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Vanderbilt Children's Hospital Nashville, Tennessee, United States
View Trial Details
Completed

A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients

NCT02367456

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • University of Alabama at Birmingham the Kirklin Clinic Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Smilow Cancer Center at Yale New Haven Hospital New Haven, Connecticut, United States
View all 33 locations
View Trial Details
Completed

Impact of Remission Induction Chemotherapy Prior to Allogeneic SCT in Relapsed and Poor-response Patients With AML

NCT02461537

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Universitätsklinikum Heidelberg Heidelberg, Baden-Wurttemberg, Germany
  • Universitätsmedizin Mannheim Mannheim, Baden-Wurttemberg, Germany
  • Robert-Bosch-Krankenhaus Stuttgart, Baden-Wurttemberg, Germany
  • Universitätsklinikum Tübingen Tübingen, Baden-Wurttemberg, Germany
View all 18 locations
View Trial Details
Completed

A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)

NCT03833180

Conditions
Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +49 more
Locations
  • City of Hope ( Site 0010) Duarte, California, United States
  • University of California - San Diego ( Site 0003) La Jolla, California, United States
  • UCLA Hematology & Oncology ( Site 0007) Los Angeles, California, United States
  • University of Nebraska Medical Center ( Site 0006) Omaha, Nebraska, United States
View all 14 locations
View Trial Details
Completed

FLYSYN in MRD Positive AML

NCT02789254

Conditions
Acute Myeloid Leukemia, Disease Attributes, Disease Progression, +10 more
Locations
  • University Hospital Tuebingen Tübingen, Baden-Wurttemberg, Germany
  • University Hospital Ulm Ulm, Baden-Wurttemberg, Germany
  • Hannover Medical School Hanover, Lower Saxony, Germany
  • University Hospital of Heidelberg Heidelberg, Germany
View Trial Details

Related conditions